Rox Resources Directors Convert Vested Performance Rights to Shares in July 2026 Transaction

Stephen Dennis Boosts Superannuation Fund Holdings by Exercising Performance Rights

On 29 July 2026, Rox Resources director Stephen Dennis exercised 500,000 vested performance rights, increasing his indirect shareholding held through The Dennis Superannuation Fund. Prior to this exercise, Mr Dennis held 2,500,000 fully paid ordinary shares indirectly, with 500,000 unexercised performance rights expiring on 31 December 2027. The exercise was completed with nil consideration, consistent with the company’s equity incentive arrangements upon meeting vesting criteria.

Post-exercise, Mr Dennis’s indirect holding rose to 3,000,000 fully paid ordinary shares within his superannuation fund, where he acts as trustee and beneficiary. This represents a 20% increase in his superannuation-held shares. The previously held 500,000 performance rights have now been fully converted to shares, leaving no unexercised rights currently disclosed. The timing aligns with the long-term incentive plan’s vesting schedule and reflects Mr Dennis’s sustained confidence in Rox Resources’ strategic direction.

Phillip Wilding Converts Significant Performance Rights Under Extended Incentive Plan

Director Phillip Wilding exercised 1,500,000 vested performance rights on 29 July 2026, converting them into fully paid ordinary shares. Before exercising, Mr Wilding held 1,600,000 shares indirectly and 1,500,000 performance rights directly eligible for conversion. The nil consideration exercise substantially increased his total ordinary shareholding across direct and indirect holdings.

Following the conversion, Mr Wilding’s aggregate shareholding reached 3,100,000 fully paid ordinary shares, including shares held in the name of Mrs Jessica Wilding. He continues to hold substantial unvested performance rights in three tranches of 3,000,000 each, expiring on 31 December 2028, 2029, and 2030. This staggered vesting structure underscores a multi-year incentive framework designed to align director interests with long-term shareholder value creation. The July 2026 exercise marks the maturation of the first tranche under this long-term plan.

Exercise Process and Compliance with Regulatory Requirements

Both directors’ share acquisitions were executed pursuant to the ASX release dated 18 March 2026, which authorized and confirmed vesting of the performance rights. These transactions were conversions of vested rights into shares rather than market purchases or new issues, a distinction important for regulatory classification.

The company confirmed no exercises occurred during closed trading periods, complying with ASX Listing Rule 12.9 and continuous disclosure obligations. The nil consideration reflects the nature of equity-based incentives where vested rights convert without additional payment. Director interest change notices filed comply with ASX Listing Rule 3.19A.2 and section 205G of the Corporations Act, promoting transparency regarding director shareholding changes.

Overview of Rox Resources Limited and Market Position

Rox Resources Limited (ABN 53 107 202 602) is an ASX-listed mineral exploration and resources development company focused on Australian and international mining sectors. The company’s governance and disclosure practices indicate a diversified portfolio approach and a commitment to aligning executive incentives with long-term shareholder value through equity-based compensation.

The disclosed performance rights exercises reflect Rox Resources’ strategic growth model, emphasizing sustained equity participation tied to multi-year performance milestones, consistent with ASX Corporate Governance Council recommendations for resource companies.

Performance Rights Vesting Schedule and Future Director Exposure

The announcement details a staggered vesting schedule for directors’ performance rights. Mr Dennis previously held 500,000 rights expiring 31 December 2027 before exercising them. Mr Wilding retains three tranches of 3,000,000 rights each, expiring on 31 December 2028, 2029, and 2030, respectively.

This extended vesting timeline demonstrates ongoing director exposure to company performance. The equal size of Mr Wilding’s tranches suggests linkage to specific performance targets rather than solely time-based vesting. Investors should monitor these future vesting events as indicators of company progress against strategic goals.

Combined Director Shareholdings Indicate Strong Board Capital Alignment

Following the exercises, Mr Dennis holds 3,000,000 shares and Mr Wilding 3,100,000 shares, alongside Mr Wilding’s 9,000,000 unvested performance rights. This substantial aggregate holding reflects significant board-level economic exposure, reinforcing alignment with shareholder interests and accountability.

Shareholding structures include superannuation fund holdings by Mr Dennis and direct and spousal holdings by Mr Wilding, consistent with tax-efficient and asset protection strategies common among senior executives. These arrangements maintain strong economic exposure despite diversified legal ownership.

Implications of Incentive Program Design and Board Alignment

The simultaneous exercise dates indicate coordinated vesting schedules managed by Rox Resources’ remuneration committee. The differing exercised amounts reflect tailored incentive allocations aligned with executive roles and tenure, with Mr Wilding’s larger unvested rights suggesting a senior position.

The company’s remuneration approach favors long-term equity incentives over cash compensation, typical in resource exploration sectors requiring sustained management continuity. Vesting schedules extending to 2030 highlight expectations for ongoing directorial oversight through multi-year project cycles. The nil consideration exercises confirm rights were earned by meeting performance conditions, supporting regulatory compliance and market integrity.

Regulatory Transparency and Continuous Disclosure Practices

Rox Resources’ timely filing of director interest change notices complies with ASX Listing Rules and Corporations Act disclosure requirements. Detailed reporting of shareholdings, performance rights terms, holding entities, and transaction details provides transparency for investors assessing director interests and potential conflicts.

The company’s confirmation that no closed period clearances were needed indicates adherence to internal securities trading policies. Separate Appendix 3Y filings for each director enhance market communication and support informed shareholder decision-making. This comprehensive disclosure approach strengthens investor confidence in governance and board accountability.

Outlook on Future Shareholder Impact and Performance Rights Vesting

The next key milestones involve the vesting of Mr Wilding’s remaining performance rights tranches expiring at the end of 2028, 2029, and 2030. Should these rights vest fully, additional ordinary shares would be issued, further increasing director shareholdings and potentially diluting existing shareholders’ interests.

The announcement does not specify the performance criteria for these rights, which investors may seek through annual reports or remuneration disclosures. The July 2026 exercise serves as a reference for anticipating future director share movements and potential impacts on earnings per share and voting power. Monitoring ongoing director interest disclosures and annual general meeting materials will be important for tracking these developments.